T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$3.3B |
| 2 |
Eli Lilly
LLY
|
+$2.75B |
| 3 |
AstraZeneca
AZN
|
+$1.98B |
| 4 |
Coupang
CPNG
|
+$1.54B |
| 5 |
Fortinet
FTNT
|
+$1.48B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$2.34B |
| 2 |
Morgan Stanley
MS
|
+$2.26B |
| 3 |
Airbnb
ABNB
|
+$2.04B |
| 4 |
Qualcomm
QCOM
|
+$1.95B |
| 5 |
NVIDIA
NVDA
|
+$1.81B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.35% |
| 2 | Healthcare | 16.19% |
| 3 | Consumer Discretionary | 15.55% |
| 4 | Financials | 12.84% |
| 5 | Communication Services | 12.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CVAC
701
DELISTED
CureVac
CVAC
| $125M | 0.01% |
1,370,088
+102,290
| +8% | +$9.92M |
|
702
Meritage Homes
MTH
$4.8B
| $124M | 0.01% |
2,708,724
+500,088
| +23% | +$21.7M |
|
703
Marathon Petroleum
MPC
$100B
| $124M | 0.01% |
2,324,565
-7,711
| -0.3% | -$389K |
|
704
Medpace
MEDP
$16.2B
| $124M | 0.01% |
756,852
-24,021
| -3% | -$3.67M |
|
|
MODV
705
DELISTED
ModivCare
MODV
| $124M | 0.01% |
834,521
+139,879
| +20% | +$21.7M |
|
706
Virtus Investment Partners
VRTS
$1.14B
| $124M | 0.01% |
524,838
-11,011
| -2% | -$2.65M |
|
707
SLM Corp
SLM
$5.22B
| $124M | 0.01% |
6,873,988
-398,102
| -5% | -$6.04M |
|
708
Texas Roadhouse
TXRH
$13.6B
| $123M | 0.01% |
1,285,167
+143,573
| +13% | +$12.5M |
|
709
Douglas Emmett
DEI
$1.99B
| $123M | 0.01% |
3,922,615
-377,934
| -9% | -$11.5M |
|
710
Quanterix
QTRX
$135M
| $123M | 0.01% |
2,103,054
+817,697
| +64% | +$55.3M |
|
711
Allogene Therapeutics
ALLO
$683M
| $122M | 0.01% |
3,456,753
-103,040
| -3% | -$3.48M |
|
|
ALXN
712
DELISTED
Alexion Pharmaceuticals
ALXN
| $121M | 0.01% |
792,319
-743,854
| -48% | -$115M |
|
713
Surgery Partners
SGRY
$1.99B
| $121M | 0.01% |
2,723,997
+2,716,573
| +36,592% | +$101M |
|
|
CSW
714
CSW Industrials
CSW
$5.59B
| $120M | 0.01% |
889,787
+228,559
| +35% | +$29M |
|
715
Teck Resources
TECK
$31.3B
| $120M | 0.01% |
6,241,219
+5,538,688
| +788% | +$112M |
|
716
Valmont Industries
VMI
$9.5B
| $119M | 0.01% |
501,731
+136,554
| +37% | +$30.3M |
|
717
Apple Hospitality REIT
APLE
$3.75B
| $119M | 0.01% |
8,182,617
+3,013,971
| +58% | +$41.9M |
|
718
Celanese
CE
$4.86B
| $119M | 0.01% |
794,795
+127,810
| +19% | +$17.6M |
|
719
Manulife Financial
MFC
$72.9B
| $119M | 0.01% |
5,531,859
+7,855
| +0.1% | +$156K |
|
720
Twist Bioscience
TWST
$7.86B
| $119M | 0.01% |
957,907
-13,070
| -1% | -$1.98M |
|
721
Pacific Biosciences
PACB
$357M
| $118M | 0.01% |
3,540,299
+221,559
| +7% | +$7.75M |
|
|
HBI
722
DELISTED
Hanesbrands
HBI
| $118M | 0.01% |
5,976,850
-129,566
| -2% | -$2.29M |
|
723
Acadia Realty Trust
AKR
$2.86B
| $117M | 0.01% |
6,188,123
-729,526
| -11% | -$12.7M |
|
724
CarMax
KMX
$8.52B
| $117M | 0.01% |
882,372
-3,606,944
| -80% | -$439M |
|
725
Tyler Technologies
TYL
$13.5B
| $117M | 0.01% |
274,720
-68,387
| -20% | -$29.5M |
|
Similar funds
T. Rowe Price Associates's Q1 2021 Portfolio in Review
As of Q1 2021, T. Rowe Price Associates held 2,908 positions worth $999B, up 2.5% from $974B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2021 filing shows 248 new, 1,171 increased, 1,334 reduced and 66 closed positions. Its largest new stake was Coupang: 33,380,859 shares worth $1.63B. The largest sale was NXP Semiconductors, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2021 buy was Coupang: 33,380,859 shares worth $1.63B.
- T. Rowe Price Associates added most to Zoom in Q1 2021, an estimated $3.3B increase.
- T. Rowe Price Associates's biggest Q1 2021 reduction was NXP Semiconductors, cutting an estimated $2.34B.
- T. Rowe Price Associates fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $205M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $999B portfolio in Q1 2021.
- T. Rowe Price Associates opened 248 new positions and closed 66 in Q1 2021.
- T. Rowe Price Associates's portfolio value rose 2.5% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q1 2021, filed 17 May 2021.